Pharmaceutical

STAT+: Texas taxpayers wanted to help the poor get heal...

Texas taxpayers wanted to help the poor get health care. Instead, they’re fundin...

STAT+: Inside Ascension’s legal fight with a Texas agen...

Ascension is locked in a legal battle with an Austin, Texas, agency over whether...

FDA warns of rare hypersensitivity reaction due to anti...

FDA warns that levetiracetam and clobazam can cause DRESS, a rare hypersensitivi...

Enveric’s EB-003 selected as lead candidate for mental ...

Enveric Biosciences has selected EB-003 as its lead drug candidate from its EVM3...

Opinion: Buprenorphine, autism diagnoses, and long Covi...

Prescribing buprenorphine, autism diagnosis, and long Covid: the most-read First...

Opinion: There’s a less intimidating alternative to Epi...

There’s a less intimidating alternative to EpiPens for dangerous allergic reacti...

Fights over methadone, harm reduction, and more: 3 addi...

Harm reduction for opioid addiction had been gaining ground. The next year will ...

We wish we’d written that: STAT staffers share their fa...

STAT staffers are sharing their favorite stories of 2023 — that they wish they h...

JPM Healthcare Conference 2024

The annual J.P. Morgan Healthcare Conference, the largest event of its kind, wil...

Opinion: Gaza, Ukraine, and other conflicts could be ac...

Military conflict can drastically accelerate the emergence and spread of drug-re...

STAT+: 3 health policies states are taking on in 2024

Next year, states are especially interested in increasing how much oversight the...

Renamed, common liver diseases might get fairer shake a...

Liver diseases have become more common and more complex. Experts decided it was ...

STAT+: UnitedHealth used secret rules to restrict rehab...

UnitedHealth used secret rules to route rehab care requests from some Medicare A...

STAT stories you might have missed in 2023

Here's a collection of STAT stories you might have missed in 2023.

Opinion: Remembering Betty Rollin, who told her breast ...

Patient advocate Betty Rollin died as she lived: on her own terms.

Bristol Myers Squibb agrees to acquire RPT company Rayz...

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition...